ATOSSA THERAPEUTICS, INC. Finite-Lived Patents, Gross
ATOSSA THERAPEUTICS, INC. (ATOS) had Finite-Lived Patents, Gross of $696.72 thousand as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2017-03-21
- 2016-12-31: Finite-Lived Patents, Gross $696.72K.
- 2016-09-30: Finite-Lived Patents, Gross $1.63M.
- 2016-06-30: Finite-Lived Patents, Gross $1.63M.
- 2016-03-31: Finite-Lived Patents, Gross $1.63M.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2016-12-31 | $696.72K 10-K · filed 2017-03-16 |
| 2016-09-30 | $1.63M 10-Q/A · filed 2017-03-21 |
| 2016-06-30 | $1.63M 10-Q/A · filed 2017-03-21 |
| 2016-03-31 | $1.63M 10-Q/A · filed 2017-03-21 |
| 2015-12-31 | $1.63M 10-Q/A · filed 2017-03-21 |
| 2015-09-30 | $1.63M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.63M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.63M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.63M 10-K · filed 2016-03-30 |
| 2014-09-30 | $4.79M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $4.79M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $4.79M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $4.79M 10-K · filed 2015-03-30 |
| 2013-09-30 | $4.70M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $4.70M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $4.70M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $4.70M 10-K · filed 2014-03-27 |
| 2012-09-30 | $4.67M 10-Q/A · filed 2013-01-22 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |